In the United States, a snail mucin peptide toner is regulated as a cosmetic by the FDA unless it also makes drug claims, in which case it enters OTC drug territory with substantially more regulatory burden. The line between permissible cosmetic claims and prohibited drug claims is one of the most commonly misunderstood issues for indie founders in the actives-forward skincare category.
Permissible cosmetic claims are those that describe how a product affects the appearance of the skin without asserting that it changes the structure or function of the body. Examples that are generally acceptable: 'visibly reduces the appearance of fine lines,' 'helps skin look firmer and more radiant,' 'hydrates and smooths the appearance of skin texture,' 'brightening toner for a more even-looking complexion.' These claims describe aesthetic or perceptible changes, not physiological ones.
Prohibited or high-risk claims on an OTC cosmetic include: 'stimulates collagen production,' 'repairs damaged skin cells,' 'clinically proven to reduce wrinkles,' 'treats hyperpigmentation,' or 'heals scarring.' These statements assert a biological mechanism or therapeutic effect, which crosses the cosmetic-drug boundary under the FD&C Act and could expose your brand to FDA warning letters or enforcement action.
Snail mucin is not an FDA-recognized OTC drug active ingredient, so any product leading with SSF as its primary claim ingredient must stay within cosmetic claim territory. Peptides like Argireline (Acetyl Hexapeptide-3) and Matrixyl (Palmitoyl Pentapeptide-4) are similarly cosmetic ingredients with no OTC drug monograph status — their efficacy claims must be framed as appearance-focused, not mechanistic.
Under MoCRA, cosmetic product labels must include: the product's identity and net quantity, the name and address of the responsible person (manufacturer, packer, or distributor), the INCI ingredient list in descending order of predominance, and any required warnings. The INCI names for key actives — 'Snail Secretion Filtrate,' 'Palmitoyl Tripeptide-1,' 'Copper Tripeptide-1,' etc. — must appear exactly as listed in the INCI dictionary.
For social media and marketing copy beyond the physical label, the same cosmetic-drug line applies. Claims made on your website, Amazon listing, or Instagram are considered labeling under FDA interpretation and can trigger enforcement if they make drug-level assertions.
If you want to make stronger efficacy claims — particularly around peptide mechanisms — you need third-party clinical or consumer perception study data and carefully worded claims that reference study outcomes rather than biological mechanisms. Your contract manufacturer's regulatory team or an independent cosmetic regulatory consultant can review your claim set before launch. AJ Cosmo Labs connects you with regulatory consultants alongside manufacturers so you can get claim review built into your launch workflow.
Ingredients in this answer: Palmitoyl Pentapeptide-4 · Argireline · Snail Secretion Filtrate · Copper Tripeptide-1
Read the full guide on Private Label Peptide Snail Mucin Toner Manufacturer Low MOQ →